Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo

Diabetes Research and Clinical Practice

Volumn 105, Issue 2, 2014, Pages 206-216

  Liu, Ping ^a   Li, Feng'ao ^b   Qiu, Mingcai ^b   He, Lanjie ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; MyD88; NF B; Renal tubulointerstitial fibrosis; TLR4

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

ALPHA SMOOTH MUSCLE ACTIN GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN GENE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; MALE; MOLECULAR PATHOLOGY; MONOCYTE CHEMOTACTIC PROTEIN 1 GENE; MYELOID DIFFERENTIATION FACTOR 88 GENE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL LIKE RECEPTOR 4 GENE; WESTERN BLOTTING;

DIABETIC NEPHROPATHY; MYD88; NF-ΚB; RENAL TUBULOINTERSTITIAL FIBROSIS; TLR4;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; IMMUNOENZYME TECHNIQUES; INFLAMMATION; KIDNEY TUBULES; MACROPHAGES; MALE; MYELOID DIFFERENTIATION FACTOR 88; NEPHRITIS, INTERSTITIAL; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWEETENING AGENTS; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84906060651     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.04.020     Document Type: Article

References (46)

1. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 2004, 43:9-17.
2. Zeisberg M., Neilson E.G. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010, 21:1819-1834.
3. Gilbert R.E., Cooper M.E. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?. Kidney Int 1999, 56:1627-1637.
4. Brocco E., Fioretto P., Mauer M., Saller A., Carraro A., Frigato F., et al. Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. Kidney Int Suppl 1997, 63:S40-S44.
5. Pickup J.C., Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 1998, 41:1241-1248.
6. Kawai T., Akira S. TLR signaling. Semin Immunol 2007, 19:24-32.
7. Anders H.J., Vielhauer V., Eis V., Linde Y., Kretzler M., Perez de Lema G., et al. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J 2004, 18:534-536.
8. Leemans J.C., Butter L.M., Pulskens W.P., Teske G.J., Claessen N., van der Poll T., et al. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS ONE 2009, 4:e5704.
9. Radford M.G., Donadio J.V., Bergstralh E.J., Grande J.P. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997, 8:199-207.
10. Bartosik L.P., Lajoie G., Sugar L., Cattran D.C. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001, 38:728-735.
11. Yokoyama T., Komori A., Nakamura M., Takii Y., Kamihira T., Shimoda S., et al. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int 2006, 26:467-476.
12. Tsuboi N., Yoshikai Y., Matsuo S., Kikuchi T., Iwami K., Nagai Y., et al. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 2002, 169:2026-2033.
13. Lin M., Yiu W.H., Wu H.J., Chan L.Y., Leung J.C., Au W.S., et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 2012, 23:86-102.
14. Qi W., Chen X., Gilbert R.E., Zhang Y., Waltham M., Schache M., et al. High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1. Am J Pathol 2007, 171:744-754.
15. Holian J., Qi W., Kelly D.J., Zhang Y., Mreich E., Pollock C.A., et al. Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cells. Am J Physiol Renal Physiol 2008, 295:F1388-F1396.
16. Ahmed A.U., Ferdous A.H., Saha S.K., Nahar S., Awal M.A., Parvin F. Hypoglycemic effect of Catharanthus roseus in normal and streptozotocin-induced diabetic rats. Mymensingh Med J 2007, 16:143-148.
17. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006, 69:213-217.
18. Tervaert T.W., Mooyaart A.L., Amann K., Cohen A.H., Cook H.T., Drachenberg C.B., et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010, 21:556-563.
19. Chow F.Y., Nikolic-Paterson D.J., Ozols E., Atkins R.C., Rollin B.J., Tesch G.H. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 2006, 69:73-80.
20. Qi X.M., Wu G.Z., Wu Y.G., Lin H., Shen J.J., Lin S.Y. Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats. Nephron Exp Nephrol 2006, 104:e147-e157.
21. Galkina E., Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 2006, 17:368-377.
22. Navarro J.F., Mora C. Role of inflammation in diabetic complications. Nephrol Dial Transplant 2005, 20:2601-2604.
23. Sassy-Prigent C., Heudes D., Mandet C., Belair M.F., Michel O., Perdereau B., et al. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000, 49:466-475.
24. Mizuno M., Sada T., Kato M., Fukushima Y., Terashima H., Koike H. The effect of angiotensin II receptor blockade on an end-stage renal failure model of type 2 diabetes. J Cardiovasc Pharmacol 2006, 48:135-142.
25. Oschatz E., Mullner M., Herkner H., Laggner A.N. Multiple organ failure and prognosis in adult patients with diabetic ketoacidosis. Wien Klin Wochenschr 1999, 111:590-595.
26. Makino C., Yanagi T., Toyama J., Yamada H., Seta K., Miura Y., et al. Case of diabetes mellitus succumbing to multiple organ failure due to hemophagocytic syndrome complicating mucormycosis. Nihon Naika Gakkai Zasshi 1999, 88:133-134.
27. Williams M.D., Nadler J.L. Inflammatory mechanisms of diabetic complications. Curr Diab Rep 2007, 72:42-48.
28. Yozai K., Shikata K., Sasaki M., Tone A., Ohga S., Usui H., et al. Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions. J Am Soc Nephrol 2005, 16:3326-3338.
29. Baeck C., Wei X., Bartneck M., Fech V., Heymann F., Gassler N., et al. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice. Hepatology 2014, 59:1060-1072.
30. Mun J.H., Kim Y.M., Kim B.S., Kim J.H., Kim M.B., Ko H.C. Simvastatin inhibits transforming growth factor-beta1-induced expression of type I collagen, CTGF, and alpha-SMA in keloid fibroblasts. Wound Repair Regen 2014, 22:125-133.
31. Devaraj S., Dasu M.R., Rockwood J., Winter W., Griffen S.C., Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008, 93:578-583.
32. Dasu M.R., Devaraj S., Zhao L., Hwang D.H., Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008, 57:3090-3098.
33. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373-384.
34. Kaur H., Chien A., Jialal I. Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am J Physiol Renal Physiol 2012, 303:F1145-F1150.
35. Hodgkinson C.P., Laxton R.C., Patel K., Ye S. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:2275-2281.
36. Jialal I., Kaur H. The role of toll-like receptors in diabetes-induced inflammation: implications for vascular complications. Curr Diab Rep 2012, 12:172-179.
37. Chow F.Y., Nikolic-Paterson D.J., Ma F.Y., Ozols E., Rollins B.J., Tesch G.H. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 2007, 50:471-480.
38. Tesch G.H. MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 2008, 294:F697-F701.
39. Devaraj S., Dasu M.R., Park S.H., Jialal I. Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 2009, 52:1665-1668.
40. Devaraj S., Glaser N., Griffen S., Wang-Polagruto J., Miguelino E., Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 2006, 55:774-779.
41. Jain S.K., Rains J.L. Toll-like receptor-4 and vascular inflammation in diabetes: editorial. Cytokine 2011, 55:446-447.
42. Li F., Liu P., Zhang X., Zhang Q., Tang S., Zhu M., et al. 1,25(OH)2D3-mediated amelioration of aortic injury in streptozotocin-induced diabetic rats. Inflammation 2013, 36:1334-1343.
43. Zhang Q., Didonato J.A., Karin M., McKeithan T.W. BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins. Mol Cell Biol 1994, 14:3915-3926.
44. Hornef M.W., Normark B.H., Vandewalle A., Normark S. Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med 2003, 198:1225-1235.
45. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P.L., Jensen F.E., et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 2002, 22:2478-2486.
46. Sender V., Lang L., Stamme C. Surfactant protein-A modulates LPS-induced TLR4 localization and signaling via beta-arrestin 2. PLoS ONE 2013, 8:e59896.